Hmgb3 is an X-linked member of a family of chromatin-binding proteins that is expressed in primitive hematopoietic cells capable of long-term hematopoietic repopulation. To examine the role of Hmgb3 in adult hematopoiesis, we generated 
Introduction
Hmgb3 is an X-linked member of the high-mobility group (HMG) superfamily of HMG proteins and is classified into the HMG-Box subfamily containing Hmgb1 and Hmgb2. 1 Little is known about the function of Hmgb3, but the high homology between Hmgb3 and other HMG-Box family members suggests that Hmgb3 may share some of the same properties with Hmgb1 and 2. Hmgb1 and 2 bind to DNA without sequence specificity and are capable of interacting with and subsequently bending linear DNA, 2,3 thereby facilitating nucleoprotein complex formation through alteration of local chromatin architecture. 4, 5 Hmgb1 and 2 can also directly interact with DNA-binding proteins (eg, Hox and Oct family members, steroid hormone receptors, RAG1 and 2, Rel, and p53) or promote interactions between protein subunits, such as between TATA-binding protein with TFIIB and TFIID with TFIIA. [6] [7] [8] HMG-Box proteins can assist in either activating or repressing transcription.
In adult vertebrates, Hmgb1 is found in all cell types, 9 whereas Hmgb3 mRNA was reported to be absent in most adult tissues. 1, 10 Previously, we have shown that in the adult mouse, Hmgb3 is expressed in bone marrow, specifically in Ter119 ϩ erythroid cells and lineage-negative (lin Ϫ ), c-kit HI , stem-cell antigen (Sca)-1 HI , interleukin-7 receptor ␣-negative (IL-7R␣ Ϫ ) cells, which are enriched for hematopoietic stem cells (HSCs). 10, 11 Other studies have shown similar Hmgb1-related mRNAs to be preferentially expressed in HSCs. 12 We demonstrated that Hmgb3 was expressed in both common lymphoid progenitors (CLPs; defined as lin Ϫ , c-kit LO , Sca-1 LO , IL-7R␣ ϩ ) 11 and common myeloid progenitors (CMPs; defined as lin Ϫ , c-kit ϩ , Sca-1 Ϫ , IL-7R␣ Ϫ ). 10, 13 Lin Ϫ , c-kit ϩ , Hmgb3 ϩ cells were capable of long-term repopulation, whereas minimal repopulation was observed with lin Ϫ , c-kit ϩ , Hmgb3 Ϫ cells. Finally, enforced expression of Hmgb3 in hematopoietic cells prevents myeloid and B-cell differentiation.
To further examine the role of Hmgb3 in hematopoiesis, we have generated an Hmgb3-deficient transgenic mouse (Hmgb3 Ϫ/Y ). Hmgb3 Ϫ/Y mice contain fewer CLPs and CMPs than wild-type mice. This deficiency is associated with an increased variability in repopulation of bone marrow by Hmgb3 Ϫ/Y HSCs (defined as lin Ϫ , c-kit HI , Sca-1 HI , IL-7R␣ Ϫ ) 11 despite their normal numbers. We observed a decreased percentage of multipotent and oligopotent progenitors in the G 2 cell cycle phase and a 48-4 delay in granulocyte colony-stimulating factor (G-CSF)-mediated mobilization of peripheral white blood cells. Hmgb3 Ϫ/Y mice exhibited a higher proportion of proliferating CLPs and myeloid progenitors (defined as lin Ϫ , c-kit LO , Sca-1 Ϫ ). Together, our data suggest a model in which Hmgb3 deficiency alters the rate of generation and differentiation of primitive hematopoietic progenitor cells.
Materials and methods

Generation of Hmgb3 knock-out mice
The 5Ј and 3Ј arms for the knock-out vector were excised from a bacterial artificial chromosome containing the entire X-linked Hmgb3 locus. The 5Ј arm consists of 8 kb encompassing a region 5Ј of the Hmgb3 locus to a site 400 bp 5Ј of the second exon. The 3Ј arm consists of 2.5 kb located immediately 3Ј of exon 5. These arms were subcloned into the pPNT targeting vector on either side of a mouse pgk-1 promoter-neomycin resistance gene cassette flanked by loxP sites. The targeting vector is designed to delete the entire coding sequence of Hmgb3 ( Figure 1A) .
The targeting vector was linearized with NotI and electroporated into TC1 embryonic stem (ES) cells as described previously. 10 Correctly targeted cells were identified by Southern blot analysis using probes outside the targeting region. Five homologous recombination events were identified among 177 G418-resistant and ganciclovir-resistant ES cell clones. Twelve to 18 ES cells from clones 27 and 87 were injected into 3.5-day-old C57BL/6 blastocysts and yielded 5 and 6 chimeras, respectively. One chimera from each clone was bred to 129/SvJ female mice, and F1 generation transgenic mice were identified by Southern blot analysis of tail DNA. Female Hmgb3 Ϫ/ϩ mice were bred to wild-type male 129/SvJ mice to produce male hemizygous mice (Hmgb3 Ϫ/Y ). Absence of Hmgb3 mRNA in bone marrow from Hmgb3 Ϫ/Y mice was confirmed by Northern blot analysis performed as previously described. 14 
Real-time PCR of TRECs
Thymocytes isolated from 6-week-old and 1-year-old Hmgb3 Ϫ/Y and littermate wild-type mice were stained with fluorescein isothiocyanate (FITC)-conjugated anti-mouse CD3 antibody (145-2C11; Pharmingen, San Diego, CA) followed by staining with anti-FITC microbeads (Miltenyi Biotech, Auburn, CA). CD3 ϩ cells were separated by magnetic bead separation using an AutoMACS Cell Sorter (Miltenyi Biotech). Primers (sense, 5Ј-CATTGCCTTTGAACCAAGCTG-3Ј; antisense, 5Ј-TTATGCA-CAGGGTGCAGGTG-3Ј; probe, 5Ј-CAGGGCAGGTTTTTGTAA AGGT-GCTCACTT-3Ј) used for T-cell receptor excision circle (TREC) amplification are located within the mouse T-cell receptor ␣/␦ (TCR␣/␦) locus, amplifying a 92-bp fragment from an excision circle formed by the recombination of ⌿J␣ with ␦Rec1. 15 Real-time polymerase chain reactions (PCRs) were performed on an ABI Prism 7700 Sequence Detector (Applied Biosystems, Foster City, CA) as described in Sempowski et al. 15 PCR reactions that amplified the mouse ␣-globin promoter (sense, 5Ј-GCTTCTCTGAC CAAGGTAGGAGG-3Ј; antisense, 5Ј-GTTGCCCGGA-CACACTTCTTAC-3Ј; probe, 5Ј-TTCTTCCCAAACTGCCATCACTG-GAGACGT-3Ј) were used as DNA-loading controls. Each reaction was performed in triplicate.
Analysis of common lymphoid and myeloid progenitors
Bone marrow cells from 6-to 8-week-old Hmgb3 Ϫ/Y and littermate wild-type mice were depleted for lineage-positive cells (lin Ϫ ) as previously described. 10 For isolation of CLPs, lin Ϫ cells were stained with allophycocyanin (APC)-conjugated anti-c-kit (2B8; Pharmingen), phycoerythrin (PE)-conjugated anti-Sca-1 (E13-161.7; Pharmingen), and PE-cyanin 5 (PE-Cy5)-conjugated anti-IL-7R␣ (A734; eBioscience, San Diego, CA) or the recommended isotype antibodies. 11 There was no detectable overlap of emission spectra between APC-conjugated c-kit and PE-Cy5-conjugated IL-7R␣ antibodies. All cells were analyzed and sorted on a FACS Vantage SE (Becton Dickinson, San Jose, CA) using 488-nm argon and 633-nm helium neon lasers. Lin Ϫ , c-kit LO , Sca-1 LO , IL-7R␣ ϩ cells were cultured in MethoCult M3630 supplemented with 100 ng/mL stem cell factor (SCF; Amgen, Thousand Oaks, CA) and 20 ng/mL Fms-like tyrosine kinase 3 ligand (Flt3L; Peprotech, Rocky Hill, NJ). CFU-Pre-Bs were scored after 7 days in culture. Lin Ϫ , c-kit LO , Sca-1 LO , IL-7R␣ ϩ cells cultured in Methocult GF M3434 supplemented with 20 ng/mL Flt3L did not form myeloid colonies.
For isolation of CMPs, lineage depletion was performed with the inclusion of anti-Sca-1 and anti-IL-7R␣ antibodies. Lin Ϫ bone marrow cells were stained with APC-conjugated anti-c-kit, PE-Cy5-conjugated anti-Sca-1 (D7; eBioscience), PE-Cy5-conjugated anti-IL-7R␣, PEconjugated anti-Fc␥RII/III (2.4G2; Pharmingen), and FITC-conjugated anti-CD34 (RAM34; Pharmingen) or the recommended isotype antibodies. 13 Staining with FITC-conjugated anti-CD34 was performed prior to staining with the remaining antibodies. Lin Ϫ , c-kit ϩ , Sca-1 Ϫ , IL-7R␣ Ϫ , Fc␥RII/III LO , and CD34 ϩ cells were cultured in Methocult GF M3434 supplemented with 20 ng/mL human Flt3L. CFU-GMs, BFU-Es, and CFU-GEMMs were scored after 7, 10, and 14 days, respectively, in culture. Lin Ϫ , c-kit ϩ , Sca-1 Ϫ , IL-7R␣ Ϫ , Fc␥RII/III LO , and CD34 ϩ cells cultured in MethoCult M3630 supplemented with 100 ng/mL SCF and 20 ng/mL Flt3L did not form CFU-Pre-B colonies.
Competitive repopulation analysis of HSC function
Bone marrow cells harvested from 6-to 8-week-old Hmgb3 Ϫ/Y or littermate wild-type mice (129/SvJ strain) were mixed in equal numbers with male C57BL/6 bone marrow cells so that 2 ϫ 10 6 cells from each strain were injected into lethally irradiated (990 rad, Cs 137 source) male 129 ϫ C57BL/6 F 1 mice (Jackson Laboratory, Bar Harbor, ME). Sixteen weeks later, Southern blot analyses were performed on recipient bone marrow DNA digested with EcoRI using a BamHI-Pst I fragment of the mouse ␤-globin gene as a probe. 14 Bone marrow cells (2 ϫ 10 6 ) from primary recipients were transplanted in lethally irradiated male 129 ϫ C57BL/6 F 1 secondary recipients, and Southern blot analyses of bone marrow DNA were performed 16 weeks after transplantation. For both primary and secondary recipients, signals corresponding to 129/SvJ ␤ maj and ␤ min and C57BL/6 ␤ S ␤-globin alleles were quantified by performing densitometry on relative band intensities captured on a PhosphorScreen and resolved on a Typhoon 8600 PhosphorImager (Amersham Pharmacia, Piscataway, NJ). Percent repopulation by either wild-type or Hmgb3 Ϫ/Y bone marrow was calculated by the formula % 129/SvJ ϭ 100 ϫ [(129 ␤maj ϩ 129 ␤min )/ (129 ␤maj ϩ 129 ␤min ϩ C57BL/6 ␤S )]. Bone marrow cells harvested from 4 secondary recipients (2 originally received transplants of wild-type marrow and 2 of Hmgb3 Ϫ/Y marrow) were then transplanted into 5 tertiary recipients each using 4 ϫ 10 6 cells per mouse.
Analysis of cell cycle status in HSCs
Bone marrow cells from groups of three 6-to 8-week-old Hmgb3 Ϫ/Y and littermate wild-type mice were pooled. Lineage depletion and isolation of the Lin Ϫ , c-kit HI , Sca-1 HI , IL-7R␣ Ϫ HSC population (or Lin Ϫ , c-kit ϩ progenitor population) was performed as described under "Analysis of common lymphoid and myeloid progenitors." Sorted cells were immediately stained with propidium iodide using the NuCycl propidium iodide (PI) staining kit (Exalpha Biologicals, Watertown, MA) according to the manufacturer's instructions before analysis by flow cytometry, which was performed on a FacsCalibur (Becton Dickinson) using a 488-nm argon laser. Cell cycle data analysis was performed using ModFit software (Verity Software, Topsham, ME). P values were generated by Student t test.
Bromodeoxyuridine staining of primitive hematopoietic progenitors
Groups of 3 Hmgb3 Ϫ/Y or littermate wild-type mice were injected with 1 mg bromodeoxyuridine (BrdU; Pharmingen) intraperitoneally for 3 consecutive days. Twenty-four hours after the final injection, bone marrow was harvested. Lineage depletion and staining with monoclonal antibodies for c-kit, Sca-1, and IL-7R␣ was performed as described in "Analysis of common lymphoid and myeloid progenitors." Cells were fixed and stained with an FITC-conjugated anti-BrdU antibody using the FITC BrdU Flow Kit (Pharmingen) according to the manufacturer's instructions before analysis by flow cytometry on a FacsCalibur using 488-nm argon and 633-nm helium neon lasers.
Cytokine mobilization of peripheral blood cells
Hmgb3 Ϫ/Y and littermate wild-type mice were splenectomized. Ten days later, mice were injected with 200 g/kg/d G-CSF (Amgen) subcutaneously for 7 days. Peripheral blood samples were removed by retroorbital bleeding prior to each round of injections and continuing 24 hours after the last injection. Blood samples were lysed with 2% acetic acid and nucleated cells counted using a hemacytometer. P values were generated by Student t test.
RT-PCR analysis of HSC mRNA
Bone marrow cells were harvested from groups of three 6-to 8-week-old Hmgb3 Ϫ/Y or littermate wild-type mice and pooled. Lineage depletion and staining with antibodies to c-kit, Sca-1, and IL-7R␣ was performed as described in "Analysis of common lymphoid and myeloid progenitors." RNA was isolated from sorted HSCs (Lin Ϫ , c-kit HI , Sca-1 HI , IL-7R␣ Ϫ ) using TriZol (Invitrogen) according to the manufacturer's instructions. Reverse transcriptase-PCR (RT-PCR) was performed as described previously using a duplex-PCR reaction with one primer pair amplifying the test gene and the second primer pair amplifying ␤2-microglobulin as an internal control. 10 Limiting dilutions of HSC mRNA were used to ensure amplifications remained within the linear range. Reactions were performed for 32 cycles at 94°C for 15 seconds, 58°C (54°C for CXCR4) for 15 seconds, and 72°C for 30 seconds. Primer pairs used for gene amplification are described as follows: CXCR4 (5Ј-GGCTGTAGAGCGAGTGTTGC-3Ј) sense, (5Ј-GTAGAGGTTGACAGTGTAGAT-3Ј) antisense 16 ; CCR3 (5Ј-TGGGCAA-CATGATGGTTGTG-3Ј) sense, (5Ј-GCTGTCTTGAGACTCATGGA-3Ј) antisense 16 ; c-kit (5Ј-GGGCAAGAGTTCCG CCTTCTT-3Ј) sense, (5Ј-GCTGCGACCACAAAGCC-3Ј) antisense 17 ; glutamate acetyltransferase 2 (Gata-2; 5Ј-GGC GTCAAGTACCAAGTGTCAC-3Ј) sense, 17 (5Ј-CTC-CCGGCCTTCTGAGCAGGAG-3Ј) antisense; Gata-1 (5Ј-GGAGCCCTCT-CAGCTCAGC-3Ј) sense, (5Ј-GCCACCAGC TGGTCCTTCAG-3Ј) antisense 17 ; c-myb (5Ј-GAGCTTGTCCAGAAATATGGT CCGAAG-3Ј) sense, (5Ј-GGCTGCCGCAGCCGGCTGAGGGAC-3Ј) antisense. 17 Test gene mRNA levels were measured and normalized to ␤2-microglobulin by performing densitometry on relative band intensities. Reverse transcriptase reactions performed without enzyme served as negative controls for genomic DNA amplification.
Results
Hematology of Hmgb3 ؊/Y mice
Homologous recombination events that removed the entire coding region of the Hmgb3 locus in male 129/SvJ ES cells ( Figure 1A ) were identified by Southern blot analysis (data not shown). As Hmgb3 is an X-linked gene, only male mice maintained on a 129/SvJ background hemizygous for the null allele (Hmgb3 Ϫ/Y ) were used for all experiments ( Figure 1B) . Northern blotting performed on bone marrow RNA confirmed the absence of Hmgb3 mRNA ( Figure 1C ). Male Hmgb3 Ϫ/Y mice are grossly normal and fertile. The absolute and differential white blood cell counts were similar in Hmgb3 Ϫ/Y mice and littermate wild-type mice (Table 1) . However, Hmgb3 Ϫ/Y mice are erythrocythemic with 10% more red blood cells (P Ͻ .01), a smaller mean cell volume (P Ͻ .01), an elevated hematocrit (P Ͻ .01), and higher levels of hemoglobin (P Ͻ .05) compared with wild-type mice (Table 1) . These data differ significantly from our previous analysis of Hmgb3 knock-in mice, 10 which have normal numbers of all hematopoietic cells. In both Hmgb3 Ϫ/Y and Hmgb3 knock-in animals, the pgk-neo gene is 
in nearly the same part of the genome indicating that the insertion of the neo gene has no effect on hematopoiesis.
Analysis of myeloid and lymphoid progenitor cells in Hmgb3 ؊/Y mice
We used clonogenic assays to quantify the numbers of erythroid, myeloid, and B-lymphoid progenitors in wild-type and Hmgb3 Ϫ/Y bone marrow (Figure 2 ; Table 2 ). Hmgb3 Ϫ/Y mice exhibit a 1.6-fold increase in the frequency of CFU-Es compared with littermate wild-type mice (P Ͻ .001; Figure 2A) . We also observed a 1.3-fold increase in the frequency of CFU-GMs (P ϭ .02; Figure 2B ) and a 1.5-fold increase in the frequency of CFU-Pre-Bs (P Ͻ .01) in Hmgb3 Ϫ/Y mice compared with wild-type mice ( Figure 2C ). We observed no difference in the frequencies of either BFU-Es ( Figure  2A ) or CFU-GEMMs ( Figure 2B ) between wild-type and Hmgb3 Ϫ/Y mice. Hmgb3 has recently been shown to have a role in the formation of a protein complex that binds to a recognition signal sequence in the TCR ␣ locus. 18 To examine T lymphopoiesis, we quantified TRECs in 6-week-old and 1-year-old Hmgb3 Ϫ/Y and littermate wild-type mice using real-time PCR. There was no difference between Hmgb3 Ϫ/Y and wild-type mice in the number of total thymocytes, CD3 ϩ thymocytes, or relative numbers of TRECs in either 6-week-or 1-year-old mice ( Figure 2D ). These results complement and extend our previous studies in which enforced expression of Hmgb3 affected the differentiation of erythroid, myeloid, and B-lymphoid cells, while T lymphopoiesis was unaffected. 10 T-cell function was not analyzed.
Analysis of primitive progenitor cells in Hmgb3 ؊/Y mice
Previously, we demonstrated through functional assays that the majority of HSCs, CLPs, and primitive myeloid progenitors expressed Hmgb3. 10 We examined the numbers of CLPs and CMPs in Hmgb3 Ϫ/Y mice compared with littermate wild-type mice by fluorescence-activated cell sorter (FACS) analysis. Representative data demonstrating isolation of the CLP and CMP populations in wild-type mice are shown in Figure 3A . Mean fluorescence of c-kit, Sca-1, or IL-7R␣ on wild-type and Hmgb3 Ϫ/Y cells was identical.
We observed a 1.6-fold decrease in the number of cells with the CLP phenotype (lin Ϫ , c-kit LO , Sca-1 LO , IL-7R␣ ϩ ; P Ͻ .05; Figure  3B ) in Hmgb3 Ϫ/Y mice compared with wild-type mice. However, we also observed a 3-fold increase in the ability of Hmgb3 Ϫ/Y CLPs to generate CFU-Pre-Bs compared with wild-type CLPs (P Ͻ .001; Figure 3C ), suggesting that although the Hmgb3 Ϫ/Y CLP population was smaller than the wild-type by phenotypic analysis, it was enriched for cells capable of differentiating into pre-B-cell progenitors. We observed 3-fold fewer cells with the CMP phenotype (defined as lin Ϫ , c-kit ϩ , Sca-1 Ϫ , IL-7R␣ Ϫ , Fc␥RII/III LO , and CD34 ϩ ; P Ͻ .05) 13 in Hmgb3 Ϫ/Y mice than in wild-type mice ( Figure 3B ). Hmgb3 Ϫ/Y CMPs also exhibited a 3-to 5-fold decrease in the ability to generate clonogenic myeloid colonies (P Ͻ .001; Figure 3D ) compared with wild-type CMPs.
Determination of Hmgb3 ؊/Y HSC repopulating ability
By FACS analysis, Hmgb3 Ϫ/Y and wild-type mice were found to contain equivalent numbers of cells with the HSC phenotype (lin Ϫ , c-kit HI , Sca-1 HI , IL-7R␣ Ϫ ; Figure 3B ). To evaluate the ability of HSCs from Hmgb3 Ϫ/Y mice to repopulate hematopoietic tissues, we mixed equivalent numbers of bone marrow cells from Hmgb3 Ϫ/Y or littermate wild-type mice (129/SvJ strain) and C57BL/6 mice and transplanted these cells into lethally irradiated 129 ϫ C57BL/6F 1 recipients. Sixteen weeks after transplantation, Southern blot analyses of bone marrow DNA were performed. Polymorphisms in the ␤-globin locus were used to differentiate between the contributions of Hmgb3 Ϫ/Y /wild-type and C57BL/6 HSCs. 19 The mean contribution in bone marrow of Hmgb3 Ϫ/Y cells is higher as Average marrow per hind limb was determined by dividing the total number of harvested bone marrow cells (from all experiments) by the number of hind limbs. Frequency was determined as the average number of CFU-Cs (see Figure 2) per cells cultured. The total number of CFU-Cs per hind limb was calculated by multiplying the average number of bone marrow cells per hind limb by the average CFU-C frequency.
predicted by the erythrocythemic phenotype and the increased number of CFU cells (CFU-Cs; Tables 1 and 2 ), but due to the high degree of variability in repopulating as reflected by significantly higher standard deviations (Table 3 ; F test, P ϭ .01), the difference between the means was not significant (t test, P Ͼ .05). Previous work by Harrison et al, 20 showed that regardless of the mean contribution of donor cells to repopulation, a small number of hematopoietic primitive progenitor cells will result in a greater degree of variability than a large number. The increased variability is consistent with the lower numbers of CLPs and CMPs that we observed.
Bone marrow cells from primary recipients (either Hmgb3 Ϫ/Y / C57BL/6 or wild-type/C57BL/6) were also used to transplant lethally irradiated 129 ϫ C57BL/6F 1 secondary recipients to measure HSC self-renewal. Southern blot analysis performed on bone marrow 16 weeks after transplantation demonstrated increased variability in repopulation among Hmgb3 Ϫ/Y recipients (Table 3 ; F test, P Ͻ .01), but the mean values were similar to the primary recipients indicating no defect in self-renewal (t test, P Ͼ .05). Tertiary recipients of bone marrow derived from secondary recipients further demonstrated no defect in Hmgb3 Ϫ/Y HSC self-renewal (data not shown).
Cell cycle and proliferative status of Hmgb3 ؊/Y hematopoietic stem and progenitor cells
To examine the mechanism behind the defect in the ability of Hmgb3 Ϫ/Y HSCs to generate CLPs and CMPs and initiate hematopoiesis, we performed cell cycle analyses on 2 bone Southern blot analyses were performed on genomic DNA isolated from bone marrow to determine the contribution to hematopoietic repopulation made by HSCs of either 129/SvJ wild-type or Hmgb3 Ϫ/Y origin (see "Materials and methods"). For each set of primary and secondary recipients, the mean percent and standard deviation of donor (Hmgb3 Ϫ/Y or 129/SvJ wild-type) derived bone marrow repopulation was determined as outlined in "Materials and methods." Statistical analyses were performed using the Student t test (mean percent values) and F test (standard deviation). marrow populations; the first was enriched for HSCs (lin Ϫ , c-kit HI , Sca-1 HI , IL-7R␣ Ϫ cells) and the second, which consisted of multipotent and oligopotent progenitors (MPPs; defined as lin Ϫ , c-kit ϩ cells), included CLPs and CMPs in addition to HSCs. We were unable to observe a difference in the cell cycle status of Hmgb3 Ϫ/Y HSCs compared with wild-type ( Figure 4A ). However, we did observe a 2-fold decrease in the number of Hmgb3 Ϫ/Y MPPs in the G 2 /M phase of the cell cycle compared with wild-type MPPs (P ϭ .02; Figure 4B-C) . The decrease in the number of Hmgb3 Ϫ/Y MPPs in G 2 /M phase did not correspond with an increase in the number of cells actively undergoing apoptosis (data not shown).
To analyze cell proliferation, we injected Hmgb3 Ϫ/Y and littermate wild-type mice with BrdU for 3 consecutive days before measuring BrdU incorporation in hematopoietic cell populations. We did not observe significant differences in BrdU incorporation between Hmgb3 Ϫ/Y or wild-type HSCs or CMPs ( Figure 4D We have previously shown that Gata-2 and c-myb mRNA is present at high levels in HSCs 17 and both of these genes have been shown to be required for definitive hematopoiesis. [21] [22] [23] [24] Furthermore, overexpression of Gata-2 and c-myb inhibits differentiation of hematopoietic cells. [25] [26] [27] We used semiquantitative RT-PCR analysis to compare the levels of these and other mRNAs in wild-type and Hmgb3 Ϫ/Y HSCs (lin Ϫ , c-kit HI , Sca-1 HI , IL-7R␣ Ϫ ; Figure 5A ). We observed a 1.7-fold increase in Gata-2 mRNA (P ϭ .03) and a 2.8-fold increase in c-myb mRNA (P Ͻ .01) in Hmgb3 Ϫ/Y HSCs compared with wild-type HSCs ( Figure 5B ). The mRNA levels for the chemokine receptor genes CXCR4 and CCR3, both of which are expressed in HSCs and are important for HSC homing, 16, 28 did not differ between wild-type and Hmgb3 Ϫ/Y HSCs ( Figure 5B ), leading to the conclusion that the stromal cell-derived factor-1 (SDF-1)/CXCR4 axis required for HSC homing was not affected by an Hmgb3 deficiency. Gata-1 and c-kit mRNA levels were also similar in wild-type and Hmgb3 Ϫ/Y HSCs ( Figure 5 ; data not shown). 
Discussion
Hmgb3, along with Hmgb1 and Hmgb2, comprise the HMG-Box subfamily of the high-mobility group proteins. Although the HMG-Box family members are more than 80% identical to each other, 29 mouse knock-out models for these genes have varied phenotypes. Hmgb1 mRNA is present in virtually all tissues and its deficiency results in lethal hypoglycemia in newborn mice. 9 Hmgb1 has been shown to interact with RAG1 and RAG2 and to play a role in V(D)J recombination, [30] [31] [32] [33] yet there are no abnormalities in the Hmgb1 Ϫ/Ϫ thymus and there are normal amounts of serum immunoglobulin and CD4 ϩ and CD8 ϩ thymocytes. Also, there was no overt defect in cellular proliferation, as the growth rate of Hmgb1 Ϫ/Ϫ fibroblasts was comparable to that of control fibroblasts. Hmgb2 is highly expressed in embryonic day 10.5 (E10.5) embryos and in the adult thymus and testes. 29 Hmgb2 Ϫ/Ϫ mice are viable, but homozygous males exhibit decreased fertility due to defective spermatogenesis. Similar to Hmgb1 Ϫ/Ϫ mice, Hmgb2 Ϫ/Ϫ mice exhibited a normal thymus, normal serum immunoglobulin levels, and a normal number of peripheral B and T lymphocytes. Our results represent the first demonstration of a role of an HMG-Box protein in hematopoiesis, namely that a deficiency of Hmgb3 leads to a decrease in the ability of HSCs to generate CLPs and CMPs and an increase in erythroid cells and precursors. We propose that any compensation by ubiquitous expression of Hmgb1 must be incomplete, at least in these cell types. Furthermore, our data provide the first direct evidence of genetic control of generation and maturation of common lymphoid and myeloid progenitors.
There are several hypotheses that could explain the impairment in the ability of Hmgb3 Ϫ/Y HSCs to initiate hematopoiesis. First, homing of Hmgb3 Ϫ/Y HSCs to the bone marrow may be inhibited.
However, the ability of Hmgb3 Ϫ/Y HSCs to transplant secondary and tertiary recipients indicates that these cells were capable of homing and normal levels of CXCR4 and CCR3 mRNA in Hmgb3 Ϫ/Y HSCs suggest that the homing axis is intact. A second explanation is that Hmgb3 Ϫ/Y mice exhibit stem cell depletion or exhaustion. However, transplantations performed with bone marrow from 1-year-old Hmgb3 Ϫ/Y mice resulted in comparable engraftment to transplantations performed with marrow from 6-to 8-week-old Hmgb3 Ϫ/Y mice (data not shown) and the differences in repopulating ability between the primary and secondary recipients were not significant. Finally, successful engraftment of secondary and tertiary recipients by Hmgb3 ϪY HSCs indicates that stem cell renewal was not affected, rendering a stem cell depletion model unlikely.
A third possibility is that Hmgb3 Ϫ/Y HSCs self-renew normally and maintain normal numbers of HSCs but are impaired in their ability to generate normal numbers of CLPs and CMPs. We propose that reduced numbers of CLPs and CMPs in Hmgb3 Ϫ/Y mice result in greater variability in the repopulation of the myeloid and lymphoid lineages. Based on our previous result that enforced expression of Hmgb3-inhibited hematopoietic differentiation, 10 we predict that CLPs and CMPs differentiate into mature phenotypes more rapidly in the absence of Hmgb3. In this model, the phenotypic HSCs would be more primitive and would be expected to have higher levels of Gata-2 and c-myb mRNA. The decrease in CLPs and CMPs in Hmgb3 Ϫ/Y mice is not due to enhanced apoptosis since there is no increase in apoptosis of Hmgb3 Ϫ/Y lin Ϫ , c-kit ϩ cells.
Our data cannot discriminate between the possibility that the decrease in Hmgb3 Ϫ/Y MPP cells in G 2 /M phase is due to an increase in the length of the G 1 or S phases or cell cycle arrest. We hypothesize that the few dividing Hmgb3 Ϫ/Y MPP cells differentiate rapidly and acquire a lin ϩ or c-kit Ϫ phenotype. The latter explanation is supported by our findings that Hmgb3 Ϫ/Y MPPs incorporate BrdU at levels greater than wild-type cells. This is also consistent with our observation that Hmgb3 Ϫ/Y bone marrow contains increased numbers of more mature myeloid, B lymphoid, and erythroid progenitor cells.
The stage at which differences in progenitor cell numbers appear varies between lineages. In the lymphoid lineage, there are fewer CLPs in Hmgb3 Ϫ/Y mice, however, they exhibit a greater potential to proliferate and differentiate into CFU-Pre-Bs. In the myeloid lineage, there are fewer CMPs in Hmgb3 Ϫ/Y mice, which have a decreased capacity to proliferate and differentiate into myeloid colonies. Hmgb3 Ϫ/Y bone marrow contained equal numbers of CFU-GEMMs, but more CFU-GMs than wild-type marrow, suggesting that the increased proliferation of myeloid cells occurs after the CFU-GEMM stage. Within the erythroid lineage, the stage at which increased proliferation occurs is after the BFU-E stage but prior to (or at) the CFU-E stage, resulting in the erythrocythemic phenotype. Overall, our data support a model in which Hmgb3 plays a significant role in regulating the balance between proliferation and differentiation in primitive stages of hematopoiesis. The amount of test gene mRNA in wild-type (n ϭ 3) and Hmgb3 Ϫ/Y (n ϭ 3) HSCs was normalized to ␤2-microglobulin mRNA (␤2) by the formula (densitometry value: test/densitometry value: ␤2-microglobulin). The data represent the pooled results of 3 independent experiments using mRNA isolated from sorted HSCs pooled from 3 mice. Standard deviation values between independent RT-PCR reactions amplifying CCR3 and Gata-1 mRNA from wild-type HSC RNA are not visible on this scale. Error bars represent standard deviation. P values were determined by Student t test.
